NCT06689813

Brief Summary

The rationale for conducting the study is based on the fact that stress urinary incontinenc is a prevalent condition among middle age or older women and Vitamin D deficiency may have clinical effects on the pelvic floor muscles and bladder function. Therefore, the study aims to explore the potential link between vitamin D levels and SUI in women in our local population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 1, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

8 months

First QC Date

November 1, 2024

Last Update Submit

November 7, 2024

Conditions

Keywords

vitamin Dstress urinary incontinencepremenopausalincontinence questionnaire short form

Outcome Measures

Primary Outcomes (1)

  • to see the effect of vitamin supplementation on severity of urinary incontinence

    Scoring of the stress urinary incontinence was done based on the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form Questionnaire. Severity of SUI was based on these scores, 1-5 (mild), 6-12 (moderate), 13-18 (severe), 19-21 (very severe).

    0,4,8 and 12 weeks of treatment

Secondary Outcomes (1)

  • Impact on qulaity of life

    0,4,8 and 12 weeks of treatment

Study Arms (2)

Vitamin D group

ACTIVE COMPARATOR

Group A participants received vitamin D supplements orally for 8 weeks along with pelvic floor exercises

Dietary Supplement: Vitamin D tablets

Placebo group

PLACEBO COMPARATOR

Group B participants received ispaghula husk tablets for 8 weeks along with pelvic floor exercises

Other: Ispaghula husk

Interventions

Vitamin D tabletsDIETARY_SUPPLEMENT

Vitamin D supplements is thought to reduce the severity of urinary incontinence.Vitamin D supplements were given to Group A

Vitamin D group

Ispaghula husk tablets were given to Group B participants

Placebo group

Eligibility Criteria

Age40 Years - 49 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemales
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women age between 40-49 years
  • Women with SUI

You may not qualify if:

  • Using hormonal medications (estrogen supplementation)
  • Undergoing urogenital-related surgery (incontinence and prolapse surgery)
  • Diabetes Mellitus
  • Participants with any disorder that interferes with vitamin D absorption, such as inflammatory bowel disease, intestinal bypass surgery, or chronic liver or kidney disease
  • Neurological disease affecting the urinary system such as multiple sclerosis, degenerative muscle disease, spinal cord injury
  • Women with urinary tract infections
  • Women taking supplements ( multivitamins or already taking vitamin D supplementation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shalamar Institute of Health Sciences

Lahore, Punjab Province, 40050, Pakistan

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Interventions

Vitamin Dispaghula seed

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Group A was given oral vitamin D supplements Group B was given isphagula husk tablets
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
second fellowship trainee in urogynaecology

Study Record Dates

First Submitted

November 1, 2024

First Posted

November 14, 2024

Study Start

February 1, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

November 14, 2024

Record last verified: 2024-11

Locations